LIRUME

Medicinal product

(Invented) name

LIRUME

Active substance (s)

Ibuprofenas

Strength

40 mg/ml

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis/Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M01AE01, Ibuprofen

Marketing authorisation holder

UAB NVT, Lietuva

Date of authorisation

2026-03-30

Date of renewal

Documents

5989_Lirume_Nerp.docx

5989_pakuotes lapelis_2026-06-26_Rp.docx

5989_pakuotes lapelis_2026-03-30_Nerp.docx

5989_Lirume_Rp.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

MT/H/0332/001/E/001

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

1 ml suspensijos yra	1 ml
Ibuprofenas	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120373	106477	1106477	buteliukas	30 ml N1 (+geriamasis švirkštas)		Nereceptinis	LT/1/26/5989/001	Netiekiama	-	2026-12-31	No	-	-
120374	106478	1106478	buteliukas	100 ml N1 (+geriamasis švirkštas)		Nereceptinis	LT/1/26/5989/002	Netiekiama	-	-	No	-	-
120375	106479	1106479	buteliukas	150 ml N1 (+geriamasis švirkštas)		Receptinis	LT/1/26/5989/003	Netiekiama	-	-	No	-	-
120376	106480	1106480	buteliukas	200 ml N1 (+geriamasis švirkštas)		Receptinis	LT/1/26/5989/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-03-30	Registruotas